Crescent Biopharma, Inc. · GETTEX:C68

Crescent Biopharma, Inc. insider trades

Crescent Biopharma, Inc.'s insiders made 1 buy and 16 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

Insider trades

TradeTradeSharesPriceValueDate
McNeill Jonathan
Officer: President and COO
Sale3,839USD 16.71US$64,150Sep 18, 2026
Brumm Joshua T
Director, Officer: Chief Executive Officer
Sale7,837USD 16.71US$131KSep 18, 2026
McNeill Jonathan
Officer: President and COO
Sale731USD 17.90US$13,085Sep 16, 2026
Brumm Joshua T
Director, Officer: Chief Executive Officer
Sale1,610USD 17.90US$28,819Sep 16, 2026
Bispham Barbara Harlin
Officer: See Remarks
Sale620USD 17.90US$11,098Sep 16, 2026
Scalzo Richard William
Officer: Chief Financial Officer
Sale568USD 17.90US$10,167Sep 16, 2026
Im Ellie Eunkyung
Officer: Chief Medical Officer
Sale623USD 17.90US$11,152Sep 16, 2026
Pinkas Jan
Officer: Chief Scientific Officer
Sale658USD 17.90US$11,778Sep 16, 2026
Lynch Ryan
Officer: See Remarks
Sale240USD 17.90US$4,296Sep 16, 2026
Fairmount Healthcare Fund II L.P.
Director, 10% owner
Buy853,450USD 14.50US$12.4MJul 16, 2026
Brumm Joshua T
Director, Officer: Chief Executive Officer
Sale42,305USD 17.99US$761KJun 22, 2026
McNeill Jonathan
Officer: President and COO
Sale20,549USD 17.99US$370KJun 22, 2026
Im Ellie Eunkyung
Officer: Chief Medical Officer
Sale1,219USD 17.99US$21,930Jun 22, 2026
Bispham Barbara Harlin
Officer: See Remarks
Sale1,218USD 17.99US$21,912Jun 22, 2026
Scalzo Richard William
Officer: Chief Financial Officer
Sale1,112USD 17.99US$20,005Jun 22, 2026
Pinkas Jan
Officer: Chief Scientific Officer
Sale1,288USD 17.99US$23,171Jun 22, 2026
Lynch Ryan
Officer: See Remarks
Sale465USD 17.99US$8,365Jun 22, 2026

Crescent Biopharma, Inc. shareholders